| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.01 | 0.9 |